Drug pipelines, open to everyone

Anyone following a disease should be able to see every drug in development, who owns it and what happens next, without a five-figure contract.

The data is public. The tools were not.

Researchers, investors and people who follow a disease closely all ask the same questions: which drugs are in development, who owns them, how far they have got and what comes next.

The answers sit in public trial registries and regulators. The tools that pull them together are built and priced for big pharma: tens of thousands a year, a sales call, and too bulky for someone who wants to follow a few areas. The other choice is days in the registries and a spreadsheet that is out of date a month later.

So we built OpenLandscape: every drug in development for a disease, target or company, read from the public sources every day.

What we hold to

A source for every fact

Every row links to the registry or regulator record it came from. Drugs we have not checked yet are marked. How we check

A fair price

Free to start, with no payment card and no time limit. $49 a month for everything. No sales call. Pricing

Open by default

The code is open source on GitHub, so anyone can see how every number is made. Your AI can read it too. For AI tools

Read every day from ClinicalTrials.gov, the EU Clinical Trials register, FDA, EMA and SEC filings.

Who we are

OpenLandscape is made by OpenLabs. Tell us what you follow and what is missing.

OpenLandscape is not related to OpenLandscape3D, a garden design app.

Feynman OÜ · registry code 16935626 · Sepapaja tn 6, 15551 Tallinn, Estonia · hello@openlandscape.app